pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
322
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
temsirolimus
Temsirolimus
Metastatic Renal Cell Carcinoma
Accord Healthcare Inc
Marketed
tepotinib hydrochloride
Tepmetko (tepotinib hydrochloride)
Non-Small Cell Lung Cancer
EMD Serono Inc
Marketed
testosterone enanthate
Xyosted (testosterone enanthate)
Secondary (Hypogonadotropic) Hypogonadism
Antares Pharma Inc
Marketed
← prev
page 11 of 11
next →
131
Pain
89
Neurology
1
thioguanine
Thioguanine
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Woodward Pharma Services LLC
Marketed
thiotepa
Thiotepa (thiotepa [INN])
Breast Cancer
STI Pharma LLC
Marketed
tisagenlecleucel
Kymriah (tisagenlecleucel)
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…
$NVS
NOVARTIS AG
Marketed
tivozanib hydrochloride
Fotivda (tivozanib hydrochloride)
Metastatic Renal Cell Carcinoma
AVEO Pharmaceuticals Inc
Marketed
tovorafenib
Ojemda (tovorafenib)
Low-Grade Glioma
$DAWN
Day One Biopharmaceuticals, Inc.
Marketed
trabectedin
Trabectedin
Ewing Sarcoma
$JNJ
JOHNSON & JOHNSON
Marketed
trastuzumab
Herceptin (trastuzumab)
Adenocarcinoma Of The Gastroesophageal Junction
Genentech Inc
Marketed
tretinoin
Tretinoin Mylan (tretinoin)
Acne Vulgaris
Mylan Pharmaceuticals Inc
Marketed
trilaciclib
Cosela (trilaciclib)
Triple-Negative Breast Cancer (TNBC)
Pharmacosmos AS
Marketed
tucatinib
Tukysa (tucatinib)
Metastatic Colorectal Cancer
Seagen Inc
Marketed
valrubicin
Valstar (valrubicin)
Bladder Carcinoma
Endo Pharmaceuticals Inc
Marketed
vemurafenib
Zelboraf (vemurafenib)
Hairy Cell Leukemia
F. Hoffmann-La Roche Ltd
Marketed
vimseltinib
Romvimza (vimseltinib)
Graft Versus Host Disease (GVHD)
Ono Pharmaceutical Co Ltd
Marketed
vinblastine sulfate
Vinblastine Sulfate
Letterer-Siwe Disease (Multifocal and Multisystemic (Diss…
Fresenius Kabi USA LLC
Marketed
vismodegib
Erivedge (vismodegib)
Basal Cell Carcinoma (Basal Cell Epithelioma)
Genentech Inc
Marketed
vorasidenib citrate
Voranigo (vorasidenib citrate)
Low-Grade Glioma
Les Laboratoires Servier SAS
Marketed
vorinostat
Zolinza (vorinostat)
Cutaneous T-Cell Lymphoma
$MRK
Merck & Co., Inc.
Marketed
ziftomenib
Komzifti (ziftomenib)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$KURA
Kura Oncology, Inc.
Marketed
ziv-aflibercept
Zaltrap (ziv-aflibercept [INN])
Metastatic Colorectal Cancer
Sanofi-Aventis US LLC
